Capio Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office

Capio Biosciences is pleased to announce receipt of an official Notice of Allowance for U.S. Patent Application Serial No.: 15/123,156 - "Biomimetic Microfluid Device for Capturing Circulating Tumor Cells” from the U.S. Patent and Trademark Office (USPTO). This patent, exclusively licensed to Capio Biosciences by the Board of Trustees of the University of Illinois further strengthens the intellectual property portfolio of Capio Biosciences, and is another step toward clinical translation of CapioCyte™ technology.




Need more details? Contact us.

 

We are here to assist. If you require further information or are interested in collaborations or partnerships, contact us by phone, email or via our social media channels.

  • White LinkedIn Icon
  • White Twitter Icon
  • White Facebook Icon

505 S. Rosa Road
Suite 10C
Madison, WI 53719

info@capiobiosciences.com

* The CapioCyte System is currently under development and not for use in diagnostic procedures.

© COPYRIGHT 2017, 2018. ALL RIGHTS RESERVED. 

Capio and CapioCyte are trademarks of Capio Biosciences.